New Considerations for a Totally Implantable Active Middle Ear Implant

Area of Science:

• Audiology
• Biomedical Engineering
• Otolaryngology

Background:

• Conventional hearing aids (CHA) have limitations for active lifestyles, visual/dexterity impairments, and fit issues.
• Inefficient middle ear transfer functions can hinder sound delivery and speech understanding with CHA.
• Totally implantable active middle ear implants (AMEI) offer a full-time amplification solution.

Purpose of the Study:

• To evaluate the efficacy and advantages of totally implantable active middle ear implants (AMEI).
• To compare AMEI performance against conventional hearing aids (CHA) for sensorineural hearing loss.
• To identify patient profiles that may benefit more from AMEI.

Main Methods:

• Review of existing safety, stability, and efficacy data for AMEI.
• Analysis of AMEI's direct-drive properties for sound delivery.
• Assessment of aided speech testing to predict AMEI benefit.

Main Results:

• AMEI provide full-time hearing amplification for moderate to severe sensorineural hearing loss.
• Direct-drive properties of AMEI improve sound delivery to the cochlea, reducing distortion.
• Simple aided speech testing can predict AMEI suitability for struggling CHA users.

Conclusions:

• Totally implantable AMEI are a viable alternative for patients with moderate to severe sensorineural hearing loss.
• AMEI offer distinct advantages over CHA for specific patient groups and hearing needs.
• Ongoing improvements in AMEI fitting strategies enhance their clinical utility.